575 related articles for article (PubMed ID: 25687773)
1. Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus.
Desikan RS; Schork AJ; Wang Y; Witoelar A; Sharma M; McEvoy LK; Holland D; Brewer JB; Chen CH; Thompson WK; Harold D; Williams J; Owen MJ; O'Donovan MC; Pericak-Vance MA; Mayeux R; Haines JL; Farrer LA; Schellenberg GD; Heutink P; Singleton AB; Brice A; Wood NW; Hardy J; Martinez M; Choi SH; DeStefano A; Ikram MA; Bis JC; Smith A; Fitzpatrick AL; Launer L; van Duijn C; Seshadri S; Ulstein ID; Aarsland D; Fladby T; Djurovic S; Hyman BT; Snaedal J; Stefansson H; Stefansson K; Gasser T; Andreassen OA; Dale AM;
Mol Psychiatry; 2015 Dec; 20(12):1588-95. PubMed ID: 25687773
[TBL] [Abstract][Full Text] [Related]
2. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases.
Ferrari R; Wang Y; Vandrovcova J; Guelfi S; Witeolar A; Karch CM; Schork AJ; Fan CC; Brewer JB; ; ; ; Momeni P; Schellenberg GD; Dillon WP; Sugrue LP; Hess CP; Yokoyama JS; Bonham LW; Rabinovici GD; Miller BL; Andreassen OA; Dale AM; Hardy J; Desikan RS
J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):152-164. PubMed ID: 27899424
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology.
Wider C; Ross OA; Nishioka K; Heckman MG; Vilariño-Güell C; Jasinska-Myga B; Erketin-Taner N; Rademakers R; Graff-Radford NR; Mash DC; Papapetropoulos S; Duara R; Uchikado H; Wszolek ZK; Farrer MJ; Dickson DW
J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):424-9. PubMed ID: 22291217
[TBL] [Abstract][Full Text] [Related]
4. Shared genetic risk loci between Alzheimer's disease and related dementias, Parkinson's disease, and amyotrophic lateral sclerosis.
Wainberg M; Andrews SJ; Tripathy SJ
Alzheimers Res Ther; 2023 Jun; 15(1):113. PubMed ID: 37328865
[TBL] [Abstract][Full Text] [Related]
5. A novel Alzheimer disease locus located near the gene encoding tau protein.
Jun G; Ibrahim-Verbaas CA; Vronskaya M; Lambert JC; Chung J; Naj AC; Kunkle BW; Wang LS; Bis JC; Bellenguez C; Harold D; Lunetta KL; Destefano AL; Grenier-Boley B; Sims R; Beecham GW; Smith AV; Chouraki V; Hamilton-Nelson KL; Ikram MA; Fievet N; Denning N; Martin ER; Schmidt H; Kamatani Y; Dunstan ML; Valladares O; Laza AR; Zelenika D; Ramirez A; Foroud TM; Choi SH; Boland A; Becker T; Kukull WA; van der Lee SJ; Pasquier F; Cruchaga C; Beekly D; Fitzpatrick AL; Hanon O; Gill M; Barber R; Gudnason V; Campion D; Love S; Bennett DA; Amin N; Berr C; Tsolaki M; Buxbaum JD; Lopez OL; Deramecourt V; Fox NC; Cantwell LB; Tárraga L; Dufouil C; Hardy J; Crane PK; Eiriksdottir G; Hannequin D; Clarke R; Evans D; Mosley TH; Letenneur L; Brayne C; Maier W; De Jager P; Emilsson V; Dartigues JF; Hampel H; Kamboh MI; de Bruijn RF; Tzourio C; Pastor P; Larson EB; Rotter JI; O'Donovan MC; Montine TJ; Nalls MA; Mead S; Reiman EM; Jonsson PV; Holmes C; St George-Hyslop PH; Boada M; Passmore P; Wendland JR; Schmidt R; Morgan K; Winslow AR; Powell JF; Carasquillo M; Younkin SG; Jakobsdóttir J; Kauwe JS; Wilhelmsen KC; Rujescu D; Nöthen MM; Hofman A; Jones L; ; Haines JL; Psaty BM; Van Broeckhoven C; Holmans P; Launer LJ; Mayeux R; Lathrop M; Goate AM; Escott-Price V; Seshadri S; Pericak-Vance MA; Amouyel P; Williams J; van Duijn CM; Schellenberg GD; Farrer LA
Mol Psychiatry; 2016 Jan; 21(1):108-17. PubMed ID: 25778476
[TBL] [Abstract][Full Text] [Related]
6. The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease.
Gerrish A; Russo G; Richards A; Moskvina V; Ivanov D; Harold D; Sims R; Abraham R; Hollingworth P; Chapman J; Hamshere M; Pahwa JS; Dowzell K; Williams A; Jones N; Thomas C; Stretton A; Morgan AR; Lovestone S; Powell J; Proitsi P; Lupton MK; Brayne C; Rubinsztein DC; Gill M; Lawlor B; Lynch A; Morgan K; Brown KS; Passmore PA; Craig D; McGuinness B; Todd S; Johnston JA; Holmes C; Mann D; Smith AD; Love S; Kehoe PG; Hardy J; Mead S; Fox N; Rossor M; Collinge J; Maier W; Jessen F; Kölsch H; Heun R; Schürmann B; van den Bussche H; Heuser I; Kornhuber J; Wiltfang J; Dichgans M; Frölich L; Hampel H; Hüll M; Rujescu D; Goate AM; Kauwe JS; Cruchaga C; Nowotny P; Morris JC; Mayo K; Livingston G; Bass NJ; Gurling H; McQuillin A; Gwilliam R; Deloukas P; Davies G; Harris SE; Starr JM; Deary IJ; Al-Chalabi A; Shaw CE; Tsolaki M; Singleton AB; Guerreiro R; Mühleisen TW; Nöthen MM; Moebus S; Jöckel KH; Klopp N; Wichmann HE; Carrasquillo MM; Pankratz VS; Younkin SG; Jones L; Holmans PA; O'Donovan MC; Owen MJ; Williams J
J Alzheimers Dis; 2012; 28(2):377-87. PubMed ID: 22027014
[TBL] [Abstract][Full Text] [Related]
7. Association of Parkinson's Disease GWAS-Linked Loci with Alzheimer's Disease in Han Chinese.
Zhu XC; Cao L; Tan MS; Jiang T; Wang HF; Lu H; Tan CC; Zhang W; Tan L; Yu JT
Mol Neurobiol; 2017 Jan; 54(1):308-318. PubMed ID: 26738859
[TBL] [Abstract][Full Text] [Related]
8. Structural study of the microtubule-associated protein tau locus of Alzheimer's disease in Taiwan.
Chang CW; Hsu WC; Pittman A; Wu YR; Hardy J; Fung HC
Biomed J; 2014; 37(3):127-32. PubMed ID: 24923570
[TBL] [Abstract][Full Text] [Related]
9. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population.
Chung SJ; Jung Y; Hong M; Kim MJ; You S; Kim YJ; Kim J; Song K
Neurobiol Aging; 2013 Nov; 34(11):2695.e1-7. PubMed ID: 23820587
[TBL] [Abstract][Full Text] [Related]
11. MAPT haplotype-stratified GWAS reveals differential association for AD risk variants.
Strickland SL; Reddy JS; Allen M; N'songo A; Burgess JD; Corda MM; Ballard T; Wang X; Carrasquillo MM; Biernacka JM; Jenkins GD; Mukherjee S; Boehme K; Crane P; Kauwe JS; Ertekin-Taner N;
Alzheimers Dement; 2020 Jul; 16(7):983-1002. PubMed ID: 32400971
[TBL] [Abstract][Full Text] [Related]
12. Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease.
Broce IJ; Tan CH; Fan CC; Jansen I; Savage JE; Witoelar A; Wen N; Hess CP; Dillon WP; Glastonbury CM; Glymour M; Yokoyama JS; Elahi FM; Rabinovici GD; Miller BL; Mormino EC; Sperling RA; Bennett DA; McEvoy LK; Brewer JB; Feldman HH; Hyman BT; Pericak-Vance M; Haines JL; Farrer LA; Mayeux R; Schellenberg GD; Yaffe K; Sugrue LP; Dale AM; Posthuma D; Andreassen OA; Karch CM; Desikan RS
Acta Neuropathol; 2019 Feb; 137(2):209-226. PubMed ID: 30413934
[TBL] [Abstract][Full Text] [Related]
13. MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.
Pastor P; Moreno F; Clarimón J; Ruiz A; Combarros O; Calero M; López de Munain A; Bullido MJ; de Pancorbo MM; Carro E; Antonell A; Coto E; Ortega-Cubero S; Hernandez I; Tárraga L; Boada M; Lleó A; Dols-Icardo O; Kulisevsky J; Vázquez-Higuera JL; Infante J; Rábano A; Fernández-Blázquez MÁ; Valentí M; Indakoetxea B; Barandiarán M; Gorostidi A; Frank-García A; Sastre I; Lorenzo E; Pastor MA; Elcoroaristizabal X; Lennarz M; Maier W; Rámirez A; Serrano-Ríos M; Lee SE; Sánchez-Juan P;
J Alzheimers Dis; 2016; 49(2):343-52. PubMed ID: 26444794
[TBL] [Abstract][Full Text] [Related]
14. Identifying the Association Between Alzheimer's Disease and Parkinson's Disease Using Genome-Wide Association Studies and Protein-Protein Interaction Network.
Liu G; Bao X; Jiang Y; Liao M; Jiang Q; Feng R; Zhang L; Ma G; Chen Z; Wang G; Wang R; Zhao B; Li K
Mol Neurobiol; 2015 Dec; 52(3):1629-1636. PubMed ID: 25370933
[TBL] [Abstract][Full Text] [Related]
15. Different MAPT haplotypes are associated with Parkinson's disease and progressive supranuclear palsy.
Ezquerra M; Pastor P; Gaig C; Vidal-Taboada JM; Cruchaga C; Muñoz E; Martí MJ; Valldeoriola F; Aguilar M; Calopa M; Hernandez-Vara J; Tolosa E
Neurobiol Aging; 2011 Mar; 32(3):547.e11-6. PubMed ID: 19879020
[TBL] [Abstract][Full Text] [Related]
16. The associations between the MAPT polymorphisms and Alzheimer's disease risk: a meta-analysis.
Zhou F; Wang D
Oncotarget; 2017 Jun; 8(26):43506-43520. PubMed ID: 28415654
[TBL] [Abstract][Full Text] [Related]
17. Association of type 2 diabetes GWAS loci and the risk of Parkinson's and Alzheimer's diseases.
Chung SJ; Kim MJ; Kim J; Ryu HS; Kim YJ; Kim SY; Lee JH
Parkinsonism Relat Disord; 2015 Dec; 21(12):1435-40. PubMed ID: 26499758
[TBL] [Abstract][Full Text] [Related]
18. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.
Harrington CR; Louwagie J; Rossau R; Vanmechelen E; Perry RH; Perry EK; Xuereb JH; Roth M; Wischik CM
Am J Pathol; 1994 Dec; 145(6):1472-84. PubMed ID: 7992850
[TBL] [Abstract][Full Text] [Related]
19. Association analysis of the GRN rs5848 and MAPT rs242557 polymorphisms in Parkinson's disease and multiple system atrophy: a large-scale population-based study and meta-analysis.
Chen Y; Cao B; Ou R; Chen X; Zhao B; Wei Q; Wu Y; Shang HF
Int J Neurosci; 2016 Oct; 126(10):947-54. PubMed ID: 26303052
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide association study identifies
Chen J; Yu JT; Wojta K; Wang HF; Zetterberg H; Blennow K; Yokoyama JS; Weiner MW; Kramer JH; Rosen H; Miller BL; Coppola G; Boxer AL;
Neurology; 2017 Feb; 88(7):669-676. PubMed ID: 28100725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
